Catena Biosciences

Revolutionary technology to make new protein based therapies

What is the Challenge?

Protein-based therapies represent an expanding majority of treatments prescribed today. Therapeutic proteins can be used to replace a protein that is abnormal or deficient in a particular disease, and are genetically engineered versions of naturally occurring human proteins. Any new protein-based drug designs take up to 12 months to produce before they can even begin testing for therapeutic activity. This leads to slower and more expensive development of better therapeutics. As the rates of diseases and conditions continue to climb and total spending on treatments worldwide increases, the need for a game changer in therapeutic discovery has never been greater.

What is the Solution?

Subscribe for the latest updates

Subscribe to EQT Foundation's press releases and updates.

@ Stiftelsen EQT Foundation 2021 . Registrated office in Stockholm, Sweden. Registration number: 802481-2821